Jaguar Health, Inc. 8-K — AI Bull & Bear Analysis

The recent 8-K filing presents a complex trade-off between short-term relief and long-term regulatory fragility. While the company has successfully avoided immediate removal from the Nasdaq, it has done so under a strict monitoring regime that leaves no room for error. The overall impact is a temporary stabilization of the stock's listing status, but the underlying financial risks—specifically the lack of a clear path to profitability and the threat of rapid dilution—remain unresolved. Investors must now weigh the benefit of continued exchange listing against the heightened risk of a sudden delisting event under the new monitoring rules.